Manhattan Scientifics Inc. ( OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate.
U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems.
For further details, please see Imagion Biosystems Press Release
About Manhattan Scientifics, Inc.
Manhattan Scientifics Inc. ( www.mhtx.com ) is focused on technology transfer and commercialization of transformative technologies.
About Imagion Biosystems
Imagion Biosystems ( www.imagionbiosystems.com ) is developing a new non-radioactive and super-sensitive diagnostic imaging technology for very early detection of cancers. Imagion is listed on the Australian Stock Exchange ( ASX ).
Forward-looking statement
This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230629885280/en/
Manhattan Scientifics, Inc.
Manny Tsoupanarias, 917-688-4158
Manny@mhtx.com
Or
Marvin Maslow, 917-923-3300
Marvin@mhtx.com